Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Documenti analoghi

• Central Adiposity and Visceral Fat in Long‐Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Exploration of an Underappreciated Risk
  di: Louise Guolla, et al.
  Pubblicazione: (2025)
• A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
  di: Cassandra Grello, et al.
  Pubblicazione: (2025)
• Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
  di: Amrutha Narayana Murthy, et al.
  Pubblicazione: (2025)
• Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
  di: Laura Almási, et al.
  Pubblicazione: (2026)
• Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
  di: Ashley C. Holland, et al.
  Pubblicazione: (2025)